124 related articles for article (PubMed ID: 1390700)
1. Conformationally restricted thrombin inhibitors resistant to proteolytic digestion.
Szewczuk Z; Gibbs BF; Yue SY; Purisima EO; Konishi Y
Biochemistry; 1992 Sep; 31(38):9132-40. PubMed ID: 1390700
[TBL] [Abstract][Full Text] [Related]
2. Design of potent bivalent thrombin inhibitors based on hirudin sequence: incorporation of nonsubstrate-type active site inhibitors.
Tsuda Y; Cygler M; Gibbs BF; Pedyczak A; Féthière J; Yue SY; Konishi Y
Biochemistry; 1994 Dec; 33(48):14443-51. PubMed ID: 7981204
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics simulations of thrombin inhibitors at the S' subsites of thrombin.
Yue SY; Konishi Y
Drug Des Discov; 1994 Jul; 12(1):1-17. PubMed ID: 7578804
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and antithrombin activity for conformationally restricted analogs of peptide anticoagulants based on the C-terminal region of the leech peptide, hirudin.
Krstenansky JL; Owen TJ; Yates MT; Mao SJ
Biochim Biophys Acta; 1988 Nov; 957(1):53-9. PubMed ID: 3179320
[TBL] [Abstract][Full Text] [Related]
5. A new class of potent thrombin inhibitors that incorporates a scissile pseudopeptide bond.
DiMaio J; Ni F; Gibbs B; Konishi Y
FEBS Lett; 1991 Apr; 282(1):47-52. PubMed ID: 2026264
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the interactions of a bifunctional inhibitor with alpha-thrombin by molecular modelling and peptide synthesis.
Yue SY; DiMaio J; Szewczuk Z; Purisima EO; Ni F; Konishi Y
Protein Eng; 1992 Jan; 5(1):77-85. PubMed ID: 1631048
[TBL] [Abstract][Full Text] [Related]
7. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ
Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168
[TBL] [Abstract][Full Text] [Related]
8. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin.
Johnson PH; Sze P; Winant RC; Hudson D; Underhill P; Lazar JB; Olsen C; Almquist R
Haemostasis; 1991; 21 Suppl 1():41-8. PubMed ID: 1894196
[TBL] [Abstract][Full Text] [Related]
9. Bifunctional thrombin inhibitors based on the sequence of hirudin45-65.
DiMaio J; Gibbs B; Munn D; Lefebvre J; Ni F; Konishi Y
J Biol Chem; 1990 Dec; 265(35):21698-703. PubMed ID: 2254323
[TBL] [Abstract][Full Text] [Related]
10. Production, properties, and thrombin inhibitory mechanism of hirudin amino-terminal core fragments.
Chang JY
J Biol Chem; 1990 Dec; 265(36):22159-66. PubMed ID: 2266119
[TBL] [Abstract][Full Text] [Related]
11. The C-terminal binding domain of hirullin P18. Antithrombin activity and comparison to hirudin peptides.
Krstenansky JL; Owen TJ; Yates MT; Mao SJ
FEBS Lett; 1990 Sep; 269(2):425-9. PubMed ID: 2401369
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structure, and structure-activity relationships of divalent thrombin inhibitors containing an alpha-keto-amide transition-state mimetic.
Krishnan R; Tulinsky A; Vlasuk GP; Pearson D; Vallar P; Bergum P; Brunck TK; Ripka WC
Protein Sci; 1996 Mar; 5(3):422-33. PubMed ID: 8868478
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of recombinant hirudins.
Stürzebecher J; Walsmann P
Semin Thromb Hemost; 1991 Apr; 17(2):94-8. PubMed ID: 1771418
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of more potent analogues of hirudin fragment 1-47 containing non-natural amino acids.
De Filippis V; Quarzago D; Vindigni A; Di Cera E; Fontana A
Biochemistry; 1998 Sep; 37(39):13507-15. PubMed ID: 9753436
[TBL] [Abstract][Full Text] [Related]
15. Thrombin-bound conformation of a cyclic anticoagulant peptide using transferred nuclear Overhauser effect (NOE), distance geometry, and NOE simulations.
Ning Q; Ripoll DR; Szewczuk Z; Konishi Y; Ni F
Biopolymers; 1994 Sep; 34(9):1125-37. PubMed ID: 7948726
[TBL] [Abstract][Full Text] [Related]
16. Nonpolar interactions of thrombin and its inhibitors at the fibrinogen recognition exosite: thermodynamic analysis.
Cheng Y; Slon-Usakiewicz JJ; Wang J; Purisima EO; Konishi Y
Biochemistry; 1996 Oct; 35(40):13021-9. PubMed ID: 8855937
[TBL] [Abstract][Full Text] [Related]
17. Interactions of hirudin-based inhibitor with thrombin: critical role of the IleH59 side chain of the inhibitor.
Tsuda Y; Szewczuk Z; Wang J; Yue SY; Purisima E; Konishi Y
Biochemistry; 1995 Jul; 34(27):8708-14. PubMed ID: 7612610
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of thrombin by synthetic hirudin peptides.
Binnie CG; Erickson BW; Hermans J
FEBS Lett; 1990 Sep; 270(1-2):85-9. PubMed ID: 2226793
[TBL] [Abstract][Full Text] [Related]
19. Structure-function relationships of hirulog peptide interactions with thrombin.
Bourdon P; Jablonski JA; Chao BH; Maraganore JM
FEBS Lett; 1991 Dec; 294(3):163-6. PubMed ID: 1756854
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of a homologous series of ketomethylene arginyl pseudodipeptides and application to low molecular weight hirudin-like thrombin inhibitors.
DiMaio J; Gibbs B; Lefebvre J; Konishi Y; Munn D; Yue SY; Hornberger W
J Med Chem; 1992 Sep; 35(18):3331-41. PubMed ID: 1527782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
